Psychiatry & Neurology, Sleep Medicine · Minneapolis, MN
NPI
1841584091
Since 2011
Specialty
Psychiatry & Neurology, Sleep Medicine
Code 2084S0012X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
701 Park Ave
Minneapolis, MN, 55415
Phone (612) 873-6113
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
266 services
Medicare patients, 2024
168
Average age 62
Drug cost, 2024
$34K
527 prescriptions
Company payments, 2025
$265
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Erin C Golden was code 99214 (office e&m - established), 61 times for 54 patients. In total Erin C Golden billed 266 services in 10 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-11-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 61 | 54 | $67.78 | $4,135 |
| 99215 Office E&M - Established | Facility | 35 | 28 | $97.17 | $3,401 |
| 95811 Sleep Study | Facility | 34 | 33 | $88.06 | $2,994 |
| 99204 Office E&M - New | Facility | 31 | 31 | $94.07 | $2,916 |
| 95810 Sleep Study | Facility | 23 | 23 | $86.28 | $1,984 |
| 99213 Office E&M - Established | Facility | 21 | 21 | $43.73 | $918 |
| G0400 Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels | Office | 18 | 18 | $168.04 | $3,025 |
| G0400 Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels | Facility | 12 | 12 | $67.98 | $816 |
By year: 2022 $27K for 312 services; 2023 $25K for 303 services; 2024 $23K for 266 services.
Medicare prescription drug claims, 2024
In 2024, the drug Erin C Golden prescribed most often to Medicare patients was Methylphenidate Hcl, with 112 prescriptions and refills. In total Erin C Golden wrote 527 Medicare prescriptions that cost $34K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methylphenidate Hcl Generic | 112 | 120 | 37 | $5,487 |
| Zolpidem Tartrate Generic | 46 | 58 | 18 | $198 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 41 | 43 | 11 | $2,148 |
| Clonazepam Generic | 32 | 50 | 12 | $213 |
| Methadone Hcl Generic | 30 | 36 | Under 11 | $556 |
| Trazodone Hcl Generic | 29 | 61 | 13 | $161 |
| Temazepam Generic | 29 | 29 | Under 11 | $330 |
| Gabapentin Generic | 27 | 57 | 12 | $703 |
| Methylphenidate Er Methylphenidate Hcl | 22 | 22 | Under 11 | $2,120 |
| Modafinil Generic | 22 | 32 | Under 11 | $1,036 |
| Eszopiclone Generic | 14 | 14 | Under 11 | $117 |
Brand drugs: 27 claims; generic drugs: 500 claims; opioid claims: 46.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Erin C Golden $265 ($265 in general payments such as food, travel and fees) from 2 companies. The largest payer was Jazz Pharmaceuticals Inc. with $150.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.